HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effects of hGH and IGF-I on body proportions.

AbstractUNLABELLED:
The differential growth effects of hGH and IGF-I on the upper/lower (U/L) body segment in relation to height (Ht) were analyzed in 15 patients with isolated Growth hormone deficiency (IGHD,:7M, 8F) mean age 5.0 +/- 3.2 (SD) years treated with hGH; 21 patients with multiple pituitary hormone deficiency including growth hormone (MPHD: 14M, 7F) aged 10.0 +/- 3.8, treated with hGH; 9 patients with Laron Syndrome (LS) (4M,5F) aged 6.9 +/- 5.6 years treated with IGF-I; 9 boys with intrauterine growth retardation (IUGR) aged 6.3 +/- 1.25 years treated by hGH; and 22 boys with idiopathic short stature (ISS) aged 8.0 +/- 1.55 years treated by hGH. The dose of hGH was 33 microg/kg/day, that of IGF-I 180-200 microg/kg/day.
RESULTS:
the U/L body segment ratio in IGHD patients decreased from 2.3 +/- 0.7 to 1.1 +/- 0.7 (p <0.001), and the Ht SDS increased from -4.9 +/- 1.3 to 2.3 +/- 1 (p < 0.001) following treatment. In MPHD patients the U/L body segment decreased from 1.1 +/- 1.1 to -0.6 +/- 1.0 (p < 0.001), and the Ht SDS increased from -3.3 +/- 1.4 to -2.5 +/- 1.0 (p < 0.009). In the LS group the U/L body segment ratio did not change with IGF-I treatment but Ht improved from -6.1 +/- 1.3 to -4.6 +/- 1.2 (p < 0.001), The differential growth response of the children with IUGR and with ISS resembled that of the children with LS.
CONCLUSIONS:
hGH and IGF-I act differentially on the spine and limbs.
AuthorsZvi Laron, Aviva Silbergeld, Rivka Kauli
JournalAnthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur (Anthropol Anz) Vol. 69 Issue 3 Pg. 255-9 (Jul 2012) ISSN: 0003-5548 [Print] Germany
PMID22928349 (Publication Type: Journal Article)
Chemical References
  • Pituitary Hormones
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
Topics
  • Adolescent
  • Body Height (drug effects)
  • Body Size (drug effects)
  • Child
  • Child, Preschool
  • Female
  • Fetal Growth Retardation
  • Growth Disorders (drug therapy)
  • Human Growth Hormone (administration & dosage, deficiency)
  • Humans
  • Infant
  • Insulin-Like Growth Factor I (administration & dosage)
  • Laron Syndrome (drug therapy)
  • Male
  • Pituitary Hormones (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: